CR

CrossBridge Bio

Houston, US · Founded 2023 · United States corporation · 2 known investors

crossbridgebio.com ↗

CrossBridge Bio, launched in 2023, develops next-generation antibody-drug conjugates (ADCs) to address a range of cancer indications. The company originated from ADC technology developed at the University of Texas Health Science Center at Houston.

Investors · 2

PO

Portal InnovationsChicago

TM

TMC Venture FundHouston

Competitors · 9

by search overlap

DI

Diabetes Prevention Program9 shared keywords

RE

ResearchGate7 shared keywords

BR

Bridgebio5 shared keywords

VA

Vaia5 shared keywords

IM

ImmuneBridge5 shared keywordsImmuneBridge is a company working in cell-based cancer immunotherapy, including research on engineered natural killer cells for solid tumor treatment.

智慧

智慧芽 (PatSnap)5 shared keywordsPatsnap builds an AI-powered platform for R&D, IP, and innovation intelligence, offering tools for patent search, novelty and FTO analysis, patent drafting, and materials and pharma research. It serves R&D leaders, IP professionals, engineers, and scientists across industries including materials, manufacturing, life sciences, pharmaceuticals, and consumer goods.

CL

Cleveland Clinic, 20224 shared keywordsCleveland Clinic is a patient-centered academic medical center providing clinical care, research, and medical education. The organization offers services ranging from primary care and virtual visits to specialized treatment, clinical trials, and advanced medical research.

DE

Dervan et al3 shared keywords

FI

Fiveable3 shared keywordsFiveable provides AI-powered exam preparation for AP classes, offering practice questions with automated scoring and personalized study tools for high school students.

Companies competing with CrossBridge Bio for the same Google search keywords, organic and paid, via search-intersection analysis.